Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$55,357,265
-$634,622 QoQ
Shares Held
353,224
-3.6% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#53
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $3,146,467,914 across 15 Drug Manufacturers - General names. NVS ranks #10 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
21,818,803 | $525,396,775 | |
| 2 | AMGN |
Amgen Inc
|
1,131,395 | $409,700,757 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
2,991,633 | $377,962,913 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
5,981,822 | $344,672,583 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,591,856 | $333,053,496 | |
| 6 | JNJ |
Johnson & Johnson
|
1,284,877 | $326,320,211 | |
| 7 | LLY |
ELI LILLY & Co
|
217,393 | $260,747,707 | |
| 8 | ABBV |
AbbVie Inc.
|
800,818 | $201,517,841 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $55,357,265 | 353,224 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $55,991,887 | 366,559 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $51,254,689 | 371,761 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $58,349,584 | 455,003 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $50,707,304 | 419,034 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $50,663,535 | 454,463 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $54,735,609 | 562,487 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $58,974,779 | 512,735 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $49,771,753 | 467,516 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $60,867,062 | 629,247 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $68,525,713 | 678,674 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $68,328,095 | 670,804 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $71,735,405 | 710,885 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $74,181,164 | 806,317 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $71,975,433 | 793,380 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $67,031,242 | 881,874 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $60,962,106 | 721,189 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $62,416,224 | 711,296 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $62,024,802 | 709,098 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $58,250,421 | 712,282 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $57,033,941 | 625,098 | Shares | Sole | 2021-10-12 | |
| 2021-03-31 | $57,336,393 | 670,758 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $57,350,360 | 607,332 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $50,884,470 | 585,148 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $44,565,933 | 510,258 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $39,220,887 | 475,693 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||